TNFSF15 and Chronic colitis: Chronic colitis models, established by transferring CD4+CD45RB^high T cells from wild-type (WT) or L-Tg mice into recombinase-activating gene-1 deficient (RAG−/−) mice, demonstrated that TL1A antibody treatment mitigated intestinal inflammation and fibrosis.